Re: Her2 and mets
The bottom line is: we really don't know. What we do know is that for Her2 positive cancer we have an extra set of treatments that can be very effective. You could see it like this: all cancers are different and some are immune to some kinds of treatment. Yours is vulnerable to both Her2 targeted therapies and those that attack the Estrogen receptor. Meaning that you have more arrows to shoot at the cancer with.
I've heard people say that nowadays Her2 positive cancers are easier to treat than some of the other types. I'm not sure this is true, but until we know for sure, I hang on to that theory.
Jacqueline
__________________
Diagnosed age 44, January 2004, 0.7 cm IDC & DCIS. Stage 1, grade 3, ER/PR pos. HER2 pos. clear margins, no nodes. SNB. 35 rads. On Zoladex and Armidex since Dec. 2004. Stopped Zoladex/Arimidex sept 2009 Still taking mistletoe shots (CAM therapy) Doing fine.
|